Sunday, September 15, 2024 12:05:27 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent ARCT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2024 09:07:29 PM
- Arcturus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference • Business Wire • 12/16/2024 09:01:00 PM
- Arcturus Therapeutics to Attend Upcoming Investor Conferences • Business Wire • 11/26/2024 09:01:00 PM
- Arcturus Therapeutics to Present at Jefferies London Healthcare Conference • Business Wire • 11/19/2024 01:00:00 AM
- Meiji Seika Pharma Announces Investment in ARCALIS, Inc. • Business Wire • 11/14/2024 06:00:00 AM
- Arcturus Therapeutics Receives Clearance from FDA to Begin H5N1 Pandemic Flu Vaccine Clinical Trial • Business Wire • 11/11/2024 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 09:25:35 PM
- Arcturus Therapeutics Announces Third Quarter 2024 Financial Update and Pipeline Progress • Business Wire • 11/07/2024 09:01:00 PM
- Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 7, 2024 • Business Wire • 10/31/2024 08:01:00 PM
- Self-Amplifying mRNA COVID-19 Vaccine Demonstrates Superior Immune Response Compared with mRNA Vaccine at 12 Months Post-Vaccination • PR Newswire (US) • 09/30/2024 12:00:00 PM
- Self-Amplifying mRNA COVID-19 Vaccine Demonstrates Superior Immune Response Compared with mRNA Vaccine at 12 Months Post-Vaccination • Business Wire • 09/30/2024 12:00:00 PM
- Japan's Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics' Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma • PR Newswire (US) • 09/13/2024 12:15:00 PM
- Japan’s Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics’ Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma • Business Wire • 09/13/2024 12:00:00 PM
- Arcturus Therapeutics Receives Clearance of an Investigational New Drug Application to U.S. Food and Drug Administration for ARCT-032, an Investigational Inhaled mRNA Therapeutic to Treat Cystic Fibrosis • Business Wire • 09/03/2024 12:30:00 PM
- Arcturus Therapeutics to Attend Upcoming Investor & Scientific Conferences • Business Wire • 08/27/2024 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 11:54:14 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/05/2024 08:50:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 08:09:24 PM
- Arcturus Therapeutics Announces Second Quarter 2024 Financial Update and Pipeline Progress • Business Wire • 08/05/2024 08:01:00 PM
- Arcturus Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference • Business Wire • 08/01/2024 08:01:00 PM
- Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on August 5, 2024 • Business Wire • 07/18/2024 11:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 07/17/2024 09:27:11 PM
- Arcturus Therapeutics Provides Updates for Ornithine Transcarbamylase (OTC) Deficiency and Cystic Fibrosis (CF) Programs • Business Wire • 07/01/2024 08:01:00 PM
- Arcturus Therapeutics Appoints Moncef Slaoui, Ph.D., to Board of Directors • Business Wire • 06/20/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/19/2024 01:01:30 AM
UAV Corp. (UMAV) Reduces Authorized Shares by 1.2 Billion, Demonstrating Commitment to Shareholders; New Authorized Share Count Approved at 800 Million • UMAV • Dec 17, 2024 12:00 PM
Avant Technologies and Ainnova Secure Advanced AI Algorithms for Early Detection of Four Additional Diseases in the U.S. • AVAI • Dec 17, 2024 8:00 AM
North Bay Resources Announces MET Results of 97% Gold Recovery with Upgrade to 11.2 Ounces per Ton Concentrate, Fran Gold Project; Completes 120 Ton Winter Ore Shipment • NBRI • Dec 16, 2024 9:00 AM
Mass Megawatts Announces the Financial Reporting Status Being Current as of Today • MMMW • Dec 16, 2024 8:18 AM
VAYK Renewed JV to Renovate Historic Landmark into "Most Sought-after Airbnb Place" in Downtown Atlanta • VAYK • Dec 12, 2024 9:36 AM
Silexion Is Addressing the MOST COMMON Human Cancer Gene Mutation With RNAi; Recent M&As in the Field Were for Tens of Billions - $SLXN • SLXN • Dec 11, 2024 9:22 AM